Senetek believes niche is big enough

Ever since Pfizer Inc.'s Viagra oral sildenafil took the market for erectile dysfunction therapies by storm, competitors have been scrambling to reposition their products or reiterate why they believe their positioning is correct.

Viagra's first victim, Vivus Inc., saw U.S.

Read the full 399 word article

How to gain access

Continue reading with a
two-week free trial.